ARCH Venture Partners
9 rounds tracked since 8 January 2026.
- Rounds
- 9
- Led
- 4
- Capital in these rounds
- $13.8B
Sectors
Countries
Rounds
- Encoded TherapeuticsDevelops precision genetic medicines for severe neurological disorders as a clinical-stage biotechnology company. $275MSeries F · 9 Sept
- OratomicLeadBuilds fault-tolerant quantum computers using reconfigurable neutral-atom qubits for useful computation. $300MSeries A · 7 Jul
- TraseLeadBuilds an agentic operating system for regulated industries. $107MSeed · 25 Jun
- Ollin BiosciencesLeadDevelops OLN324 therapy for diabetic macular edema and wet age-related macular degeneration. $330MSeries B · 24 Jun
- PrometheusDevelops AI tools for engineering and manufacturing applications. $12BSeries B · 12 Jun
- SonoTheraDevelops ultrasound-mediated genetic medicines for therapeutic use. $125MSeries B · 10 Jun
- CREATE MedicinesLeadDevelops in vivo CAR cell therapies targeting autoimmune disease and oncology. $122MSeries B · 14 May
- MiradorDevelops clinical-stage therapies for immuno-fibrotic diseases through a multi-asset pipeline $250MSeries B · 12 Jan
- Parabilis MedicinesDevelops oncology therapies, including FOG-001 (zolucatetide), using its Helicon platform. $305M8 Jan
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise